EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis

Yu-Han Chen iD, Andrea Yue-En Sun iD, Karishma Narain iD, Wei-Cheng Chang, Chieh Yang, Po-Huang Chen, Hong-Jie Jhou, Ming-Shen Dai, Natasha Rastogi, Cho-Hao Lee iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01597-24 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Yu-Han Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Englewood Hospital and Medical Center, Englewood, New Jersey, USA. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Anti-Bacterial Agents, Febrile Neutropenia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Febrile neutropenia (FN) is a serious complication in patients with hematologic malignancies following treatments such as chemotherapy and hematopoietic stem cell transplantation. It is typically managed with broad-spectrum antibiotics (BSA), but the optimal duration of BSA therapy remains controversial. This meta-analysis aimed to assess the clinical efficacy and safety of early antibiotic de-escalation in patients with hematologic malignancies with FN before hematopoietic recovery, compared to those who continued BSA until hematopoietic recovery. Statistical analysis included pooled odds ratios (OR) for mortality and secondary adverse outcomes, along with subgroup analysis to identify patient populations that may benefit from early de-escalation. Ten studies, mostly retrospective observational designs, were included. Early de-escalation significantly reduced mortality risk (OR 0.20, 95% CI 0.06–0.69). Subgroup analyses showed mortality benefits in older patients (>55 years old, OR 0.42, 95% CI 0.18–0.98) and in higher-quality studies (OR 0.07, 95% CI 0.01–0.62). No significant differences were observed for infection-related ICU admissions, bacteremia, recurrent fever, or Clostridium difficile infection (CDI). In conclusion, early de-escalation of BSA in patients with hematologic malignancies and developing FN after treatment significantly reduces mortality risk without increasing major adverse events. These findings support the use of early de-escalation and highlight the need for personalized strategies to improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsAnti-Bacterial AgentsFebrile NeutropeniaHumansBacteremiaHematopoietic Stem Cell Transplantation

Stichwörter der Autor:innen

antibiotic de-escalationbroad-spectrum antibioticsfebrile neutropeniahematologic malignancieshematopoietic stem cell transplantationmortality reduction

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Englewood Hospital and Medical Center, Englewood, New Jersey, USA.
  • College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Ophthalmology, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.
  • Jacob's School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
  • Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan.

ORCID-Profile: Yu-Han Chen, Andrea Yue-En Sun, Karishma Narain, Cho-Hao Lee

Zitieren

APA

Chen, Y. H., Sun, A. Y. E., Narain, K., Chang, W. C., Yang, C., Chen, P. H., Jhou, H. J., Dai, M. S., Rastogi, N., & Lee, C. H. (2025). Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01597-24

Vancouver

Chen YH, Sun AYE, Narain K, Chang WC, Yang C, Chen PH, et al. Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01597-24

BibTeX
@article{Chen2025,
  author = {Chen, Yu-Han and Sun, Andrea Yue-En and Narain, Karishma and Chang, Wei-Cheng and Yang, Chieh and Chen, Po-Huang and Jhou, Hong-Jie and Dai, Ming-Shen and Rastogi, Natasha and Lee, Cho-Hao},
  title = {Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01597-24}
}
Kostenlos starten →